ABOUT

Mucosis B.V. is a clinical stage Dutch biotechnology company developing innovative mucosal vaccines that can be applied needle-free via the nose or mouth. Mucosis’s lead product candidate is SynGEM®, an intranasal vaccine to prevent respiratory syncytial virus infection.


Company: Mucosis
Agency: Instinctif Partners
Year: 2015
Illustrations & animation: Funda Topaloglu